GeneDx Holdings is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO Katherine A. Stueland, with a market cap of $1.8B.
Common questions about GeneDx Holdings
GeneDx Holdings is scheduled to report earnings for Q1 2026 on April 29, 2026. Analysts estimate revenue of $111.7M.
GeneDx Holdings has approximately 1,000 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.